CAS 84494-72-4|cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester
| Common Name | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester | ||
|---|---|---|---|
| CAS Number | 84494-72-4 | Molecular Weight | 356.541 |
| Density | 0.9±0.1 g/cm3 | Boiling Point | 443.5±24.0 °C at 760 mmHg |
| Molecular Formula | C24H36O2 | Melting Point | / |
| MSDS | ChineseUSA | Flash Point | 102.1±21.2 °C |
Names
| Name | Ethyl cis-4,7,10,13,16,19-Docosahexaenoate |
|---|---|
| Synonym | More Synonyms |
BiologicalActivity
| Description | Ethyl cis-4,7,10,13,16,19-Docosahexaenoate, the ethyl ester of Docosahexaenoate (DHA), is enriched in the ethyl ester fraction by the selective alcoholysis of fatty acid ethyl esters originating from tuna oil with lauryl alcohol. |
|---|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Metabolic Disease |
| In Vitro | Ethyl cis-4,7,10,13,16,19-Docosahexaenoate (Ethyl docosahexaenoate; E-DHA) is efficiently enriched by the selective alcoholysis of ethyl esters originating from tuna oil with lauryl alcohol using immobilized lipase[1]. |
| References | [1]. Yuji Shimada, et al. Purification of ethyl docosahexaenoate by selective alcoholysis of fatty acid ethyl esters with immobilized Rhizomucor miehei lipase. J Am Oil Chem Soc. 1998 Nov, 75(11): 1565–1571. |
Chemical & Physical Properties
| Density | 0.9±0.1 g/cm3 |
|---|---|
| Boiling Point | 443.5±24.0 °C at 760 mmHg |
| Molecular Formula | C24H36O2 |
| Molecular Weight | 356.541 |
| Flash Point | 102.1±21.2 °C |
| Exact Mass | 356.271515 |
| PSA | 26.30000 |
| LogP | 7.77 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.504 |
| InChIKey | ITNKVODZACVXDS-YATCGRJWSA-N |
| SMILES | CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC |
| Storage condition | −20°C |
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves |
|---|---|
| Hazard Codes | Xi |
| Safety Phrases | S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
Articles27
More Articles| Docosahexaenoic acid counteracts attenuation of CD95-induced cell death by inorganic mercury. Toxicol. Appl. Pharmacol. 282(1) , 61-7, (2015) In the United States the principal environmental exposure to mercury is through dietary consumption of sea food. Although the mechanism by which low levels of mercury affect the nervous system is not ... | |
| Protective effects of prescription n-3 fatty acids against impairment of spatial cognitive learning ability in amyloid β-infused rats. Food Funct. 2(7) , 386-94, (2011) Deposition of amyloid β peptide (Aβ) into the brain causes cognitive impairment. We investigated whether prescription pre-administration of n-3 fatty acids improves cognitive learning ability in young... | |
| Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake. Am. J. Hematol. 83(6) , 437-45, (2008) Newly described lipoxygenase (LOX)-generated lipid mediators, that is, resolvins and protectins as well as lipoxins, are both anti-inflammatory and proresolving. We aimed to determine whether these li... |
Synonyms
| Ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate |
| 4,7,10,13,16,19-Docosahexaenoic acid, ethyl ester, (4E,7E,10E,13E,16E,19E)- |
| Ethyl (4E,7E,10E,13E,16E,19E)-4,7,10,13,16,19-docosahexaenoate |
| cis-4,7,10,13,16,19-docosahexaenoic acid ethyl ester |
| Ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,16,19-docosahexaenoate |
| MFCD00056293 |
| 4,7,10,13,16,19-Docosahexaenoic acid, ethyl ester, (4Z,7Z,10Z,13Z,16Z,19Z)- |
| 4,7,10,13,16,19-docosahexaenoic acid ethyl ester |
| 4,7,10,13,16,19-Docosahexaenoic acid, ethyl ester |
